Alcon: all 719 studies
Page 6 of 8. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube SurgeryWithdrawnNCT01908764Phase 1
- Multi-Center Clinical Evaluation of Two Daily Disposable Contact LensesCompletedNCT01898260Not applicable
- Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery.CompletedNCT01818115Not applicable
- A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 DaysCompletedNCT01789736Phase 2
- A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 MonthsCompletedNCT01699464Phase 2
- Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in RussiaWithdrawnNCT01696383Phase 4
- A Comparison of Manufacturing Processes for AIR OPTIX® COLORS Contact LensCompletedNCT01614678Not applicable
- Optimization of Assessment and Grading for Lid Wiper EpitheliopathyCompletedNCT01611922
- Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9CompletedNCT01601665
- Creating LASIK Flaps With the LenSx Femtosecond LaserCompletedNCT01556893Phase 1
- VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract SurgeryWithdrawnNCT01515826Phase 3
- Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior TherapyTerminatedNCT01514721Phase 4
- Travacom Post Marketing Surveillance StudyWithdrawnNCT01510132Phase 4
- A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic SolutionTerminatedNCT01485822
- In Vivo Measurement of Corneal Epithelial Changes in Dry Eye PatientsCompletedNCT01483989Not applicable
- AR-12286 Fixed Dose Combination to Lower Elevated Intraocular PressureCompletedNCT01474135Phase 2
- Patient Preference Comparison of AZARGA Versus COSOPT in Patients With GlaucomaCompletedNCT01471158Phase 4
- Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%WithdrawnNCT01452009Phase 3
- Asian Clinical Evaluation of an Investigational Contact Lens for Cosmetic EffectCompletedNCT01446835Not applicable
- Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up TimeWithdrawnNCT01417013Not applicable
- Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular EmulsionCompletedNCT01368198Not applicable
- Evaluation of the Performance of AIR OPTIX® COLORSCompletedNCT01338402Not applicable
- 24-hour Efficacy of AR-12286CompletedNCT01330979Phase 2
- Safety and Comfort of AL-4943A Ophthalmic SolutionCompletedNCT01326858Phase 1
- AL-54478 Proof of Concept StudyCompletedNCT01318252Phase 2
- Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412CTerminatedNCT01312454Phase 2
- A Multi-Site Post Marketing Surveillance Study for Systane in Indian PatientsCompletedNCT01311609Phase 4
- AR-12286 in Combination With LatanoprostCompletedNCT01302249Phase 2
- A Comparison of Visual Function After Bilateral Implantation of Presbyopia Correcting Intraocular LensesCompletedNCT01299155Not applicable
- Divided Dose of TRAVATAN®CompletedNCT01298687Phase 2
- Patient Perception Study for AL-4943ACompletedNCT01294969Phase 4
- A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)CompletedNCT01294956Not applicable
- A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic ConjunctivitisCompletedNCT01272089Phase 4
- Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and SalineCompletedNCT01252121Not applicable
- Formulation Comparison in Normal VolunteersCompletedNCT01250197Phase 1
- Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial ConjunctivitisWithdrawnNCT01238783Phase 2
- Fitting Children With Contact LensesCompletedNCT01233089Not applicable
- Safety and Efficacy of Changing to DuoTrav From Prior TherapyCompletedNCT01230736Phase 4
- An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry EyeCompletedNCT01223040Not applicable
- Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4CompletedNCT01215045
- AcrySof Toric Clinical ResultsCompletedNCT01214863
- Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract SurgeryCompletedNCT01199510Phase 4
- Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%CompletedNCT01198782Phase 4
- Visual Outcomes After Bilateral Surgical Cataract Phacoemulsification: AcrySof Toric IOL Implantation Compared to Monofocal IOL ImplantationTerminatedNCT01192321Phase 4
- An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations, and Functional Vision Correlation Following Intraocular Lens (IOL) ImplantationCompletedNCT01190631Not applicable
- An Evaluation of the Nighttime Retention of Effect of an Investigational Lubricant Eye Drop (FID 115958D)CompletedNCT01165164Not applicable
- To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye DropsCompletedNCT01160133Not applicable
- To Assess the Safety and Efficacy of Travacom in Patients With Uncontrolled Intraocular PressureCompletedNCT01159756Phase 4
- An Evaluation of the Daytime Use of an Investigational Lubricant Eye DropCompletedNCT01139372Not applicable
- Clinical Comparison of Two Daily Disposable Lenses Among Daily Disposable Lens WearersCompletedNCT01134211Not applicable
- An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular DrynessCompletedNCT01132287Not applicable
- Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular HypertensionCompletedNCT01111890Phase 4
- Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in Children 6 Months to 12 YearsTerminatedNCT01111877
- Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric PatientsCompletedNCT01109485Phase 4
- Efficacy of Systane Ultra in Post Menopausal Women With Dry EyeCompletedNCT01105910Phase 4
- A Comparative Pilot Study Of High-Order Aberrations With Aspheric IOL Models SN60WF and ZCB00CompletedNCT01105585Not applicable
- A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic BlepharitisCompletedNCT01102244Phase 3
- Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal StainingCompletedNCT01100424Not applicable
- Changes in Invitro and ex Vivo Lens Metrology With Daily Wear Contact LensesCompletedNCT01100411Not applicable
- Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye SubjectsCompletedNCT01086774Phase 4
- Evaluation of FID 114657 in Sjogren's Syndrome SubjectsCompletedNCT01079871Not applicable
- Evaluation of FID 114657 in Dry Eye SubjectsCompletedNCT01079858Not applicable
- Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Lubricant Eye GelCompletedNCT01077011Not applicable
- Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Eye OintmentCompletedNCT01076998Not applicable
- Visual Function After Implantation of AcrySof® Toric LensTerminatedNCT01074606Phase 4
- Safety and Efficacy of Moxidex OticTerminatedNCT01071902Phase 3
- Compliance and Contamination in Soft Contact Lens WearersCompletedNCT01069237
- Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer ThicknessCompletedNCT01066988Not applicable
- Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01060579Phase 2
- Bioavailability of Nutrients Contained in Softgel Capsules vs TabletsCompletedNCT01057966Phase 4
- ELAZOP Switching Study in KoreaCompletedNCT01055366Phase 4
- Evaluation of the Repeated Usage of Systane Ultra EyedropCompletedNCT01051804Phase 4
- A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)CompletedNCT01045733Not applicable
- An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic ConjunctivitisCompletedNCT01037179Phase 3
- An Evaluation of the Safety and Efficacy of FID 114657CompletedNCT01030237Not applicable
- Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial FloraCompletedNCT01027494
- Tear Film Break-Up Time Evaluation of FID 114657CompletedNCT01023464Not applicable
- AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated InflammationCompletedNCT01001091Phase 2
- Clinical Evaluation of the Causes of Contact Lens Related Dry EyeCompletedNCT00995189Not applicable
- WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment ExaminationCompletedNCT00992563Phase 2
- Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese SubjectsCompletedNCT00987272Phase 3
- Acute Comfort and Haze Profile of FID 114657CompletedNCT00983203Not applicable
- A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact LensesCompletedNCT00982046Not applicable
- Efficacy and Safety of Adding Azarga to Prostaglandin MonotherapyCompletedNCT00966576Phase 4
- Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 DaysCompletedNCT00946777Not applicable
- Subjective and Conjunctival Response to Edge Design of Different Silicone HydrogelsCompletedNCT00940459Not applicable
- Macular Edema Incidence/Severity Reduction With NevanacTerminatedNCT00939276Phase 3
- Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.CompletedNCT00938951Not applicable
- Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) PatientsWithdrawnNCT00929747Phase 4
- Acute Clinical Evaluation of Multi-purpose Solutions (MPS) in Soft Contact Lens WearersCompletedNCT00929487Not applicable
- Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00928590Phase 3
- DuoTrav APS Versus XALACOM® in Ocular Surface HealthTerminatedNCT00912054Phase 3
- A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)CompletedNCT00902200Phase 2
- An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral ConjunctivitisTerminatedNCT00901693Phase 2
- A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry EyeCompletedNCT00893139Phase 2
- Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface HealthCompletedNCT00892762Phase 3
- To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen ChallengeWithdrawnNCT00881673Phase 2
- Investigation of Corneal Aberrations and Visual Outcomes in Patients Implanted With an AcrySof Toric Intraocular Lens (IOL)WithdrawnNCT00878839Not applicable
- Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00872651Phase 3
- Safety and Efficacy Study of DuoTrav APS Versus DuoTravWithdrawnNCT00862472Phase 3